豪森藥業
      • Overview
      • 1995 Initial establishment
        A principal subsidiary of Hansoh Pharma (03692.HK)
        7
        Launched innovative drugs
        Top 100
        Pharmaceutical companies worldwide
        Top 3
        China's best Industrial enterprises in pharmaceutical R&D pipeline

      Therapy Areas

      • Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        Anti-tumor
        We focus on the develoment of new drugs in the field of common and hostile cancers.Our innovative medicine programs in clinical trials include HS-20106 injection, HS-20105 injection, HS-20117 injection, HS-10516 capsules, HS-10382 tablets, HS-10370 tablets, HS-10502 tablets, HS-10365 capsules, HS-20089 injection, HS-20093 injection, HS-10352 tablets, HS-10241 tablets, etc.
        More +
      • Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        Anti-infectives
        We focus on the development of new drugs in the fields of antiviral, anti-complex bacterial infection and anti-fungal infection. Our innovative medicine programs in clinical trials includeCitric Acid Erythorbate tablets, etc.
        More +
      • CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        CNS Diseases
        We focus on the development of new drugs in the fields of psychiatric and neurological disorders.Our innovative medicine programs in clinical trials include HS-10380 tablets, HS-10506 tablets, HS-10353 capsules, HS-10509 tablets, etc.
        More +
      • Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        Metabolic Diseases
        We focus on the development of new drugs in the field of metabolic diseases such as diabetes and obesity. Our innovative medicine programs in clinical trials include HS-10511 tablets, HS-20094 injection, HS-10384 tablets, HS-10518 capsules, HS-10390 tablets, HS-10501 tablets, and HS-10398 capsules, etc.
        More +
      • Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        Autoimmune Diseases
        We focus on the development of new drugs in the field of autoimmune diseases. Our innovative medicine programs in clinical trials includeHS-10374 tablets etc.
        More +
      R&D
      Innovation
      Jiangsu Hansoh Pharma Research Institute
      Jiangsu Hansoh Pharma Research Institute
      More
      Jiangsu Hansoh Pharma Administrative R&D Center
      Jiangsu Hansoh Pharma Administrative R&D Center
      More
      • Substantial investment on R&D
        In 2024, R&D expenditure was RMB2,702 million, and accounted for 22.0% of the revenue.
      • Competitive R&D pipeline
        More than 60 clinical trials of innovative drug candidates being investigated, covering 40 innovative drug candidates.
      • Highly efficient capability to discover innovative drugs
        The R&D pipeline covers peptides , small molecules, biologics, ADC drugs, siRNAs, and more.
      A broader world, let's discover together
      Join Hansoh Pharma +
      Work with us
      We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
      Join Hansoh Pharma +
      亚洲毛片αv无线播放一区| 另类图片亚洲校园小说区| 亚洲成人一区二区| 亚洲日韩中文无码久久| 亚洲一区精品视频在线| 亚洲国产精品无码观看久久| 亚洲精品国产美女久久久| 亚洲A∨精品一区二区三区下载| 久久精品国产亚洲av高清漫画| 亚洲成a人片在线观看久| 毛片亚洲AV无码精品国产午夜| 亚洲伊人久久大香线蕉| 国产AV无码专区亚洲A∨毛片| 亚洲AV无码成H人在线观看| 国产精品亚洲一区二区三区久久 | 亚洲精品GV天堂无码男同| 亚洲一区二区三区91| 亚洲黄色在线电影| 亚洲欧洲日产国码久在线观看 | 亚洲视频在线观看视频| 亚洲美女视频免费| 亚洲AV永久精品爱情岛论坛| 亚洲精品动漫人成3d在线| 亚洲中文字幕无码av| 亚洲系列中文字幕| 亚洲一级大黄大色毛片| 亚洲天堂2016| 亚洲人成在线精品| 色在线亚洲视频www| 亚洲欧美第一成人网站7777 | 亚洲综合一区二区精品久久| 久久亚洲精品专区蓝色区| 亚洲精品宾馆在线精品酒店| mm1313亚洲国产精品美女| 亚洲gay片在线gv网站| 亚洲成A人片77777国产| 亚洲乱码中文字幕综合| 亚洲精品成人av在线| 亚洲另类精品xxxx人妖| 亚洲精品国产首次亮相| 亚洲国产成人久久笫一页|